Shree Pacetronix Q2 FY27 Profit Falls 15.4% to ₹1.12 Crore

Shree Pacetronix Limited reported consolidated profit after tax of ₹1.12 crore for the quarter ended September 30, 2026, a 15.4% year-on-year decline, while revenue from operations fell 7.6% to ₹6.14 crore. The Board approved the unaudited Q2 FY27 results on November 13, 2026, along with an unmodified limited review report.

What did Shree Pacetronix report for Q2 FY27?

Shree Pacetronix reported consolidated revenue from operations of ₹6.14 crore in Q2 FY27, compared with about ₹6.60 crore in Q2 FY26, based on the reported year-on-year decline of 7.6%. Consolidated total income was ₹6.20 crore, including ₹0.05 crore of other income, while profit after tax stood at ₹1.12 crore.

The company reported profit before tax of ₹1.52 crore for the quarter after consolidated expenses of ₹4.68 crore. Its reported operating margin was 24.2%, lower than 27.3% a year earlier, although it improved from 20.4% in the preceding quarter. The figures indicate that quarterly profitability improved sequentially despite lower revenue than the year-earlier period.

On a standalone basis, revenue from operations was also ₹6.14 crore and total revenue was ₹6.20 crore. Standalone profit before tax was ₹1.51 crore and profit after tax was ₹1.11 crore, after a tax expense of ₹0.40 crore.

How did the Board and auditor deal with the results?

Shree Pacetronix's Audit Committee reviewed the financial statements and the Board of Directors approved the unaudited standalone and consolidated results on November 13, 2026. The approval covered the quarter and half year ended September 30, 2026.

The Board also took on record the statements of assets and liabilities and cash-flow statements for the half year. Agarwal Patel and Sinhal, the company's statutory auditor, issued an unmodified limited review opinion on the reported results. An unmodified opinion means the auditor did not modify its conclusion on the financial information reviewed.

The filing did not disclose a dividend, fundraise or share issuance alongside the result announcement. The Board meeting was the third meeting of the company's 2026-27 financial year and was held after the company had scheduled consideration of its Q2 and first-half results.

How did the first half of FY27 compare with the quarter?

Shree Pacetronix recorded consolidated revenue from operations of ₹11.12 crore for the half year ended September 30, 2026, with consolidated profit after tax of ₹1.87 crore. Standalone revenue from operations for the same period was ₹11.04 crore and standalone profit after tax was ₹1.87 crore.

The Q2 consolidated revenue of ₹6.14 crore was higher than the ₹4.90 crore reported for Q1 FY27 in the supplied quarterly comparison. Consolidated net profit rose from ₹0.80 crore in Q1 to ₹1.12 crore in Q2, representing reported quarter-on-quarter growth of 37.5%.

However, the year-on-year comparison remained weaker. The reported Q2 FY27 consolidated net profit of ₹1.12 crore was lower than about ₹1.30 crore in Q2 FY26, while revenue was lower than the prior year's ₹6.60 crore. The data therefore shows a sequential improvement from Q1 but a decline against the same quarter a year earlier.

What do the balance sheet and cash-flow figures show?

Shree Pacetronix reported consolidated total assets of ₹26.08 crore as of September 30, 2026. Consolidated equity stood at ₹19.97 crore and total liabilities were ₹6.12 crore. On a standalone basis, total assets were ₹26.12 crore, equity was ₹19.97 crore and liabilities were ₹6.15 crore.

For the first half of FY27, consolidated operations generated net cash of ₹2.49 crore. The company used ₹1.01 crore in investing activities and ₹2.03 crore in financing activities, resulting in a net decrease of ₹0.55 crore in cash and cash equivalents.

Standalone cash flow followed a similar pattern. Net cash from operating activities was ₹2.41 crore, while investing and financing activities used ₹1.02 crore and ₹1.95 crore, respectively. The resulting net decrease in cash and cash equivalents was ₹0.56 crore.

Why do the Q2 FY27 results matter to investors?

Shree Pacetronix manufactures and sells implantable cardiac pacemakers through its subsidiary in India and international markets. For investors, the quarterly filing provides updated information on the company's revenue, profitability, assets and cash generation from this medical-device business.

The reported revenue and profit declines on a year-on-year basis are relevant because both the top line and operating margin were lower than in Q2 FY26. At the same time, the improvement from Q1 FY27 shows that Q2 profit and margin were stronger on a sequential basis. The filing itself does not provide growth guidance or explain the specific reasons for the year-on-year movement.

The unmodified limited review offers procedural confirmation that the auditor did not identify a reason to modify its conclusion on the unaudited results. Investors will also note the difference between cash generated from operations and the overall cash decline, which reflects reported uses of cash for investing and financing during the first half.

Conclusion

Shree Pacetronix closed Q2 FY27 with consolidated revenue of ₹6.14 crore and profit after tax of ₹1.12 crore. While both figures declined from the year-earlier quarter, the company's profit, revenue and operating margin improved from Q1 FY27, and first-half operating cash flow was ₹2.49 crore on a consolidated basis.

The next point to watch is the company's subsequent quarterly disclosure for evidence on whether the sequential recovery in revenue and profitability continues. The current filing contains no new growth guidance, dividend decision, fundraising plan or share issuance proposal.